OMB APPROVAL |
||
OMB Number: 3235-0145 |
||
Expires: February 28, 2009
|
||
Estimated average burden hours per response...10.4 |
||
o | Rule 13d-1(b) | |
o | Rule 13d-1(c) | |
þ | Rule 13d-1(d) |
CUSIP No. |
230770109 |
1 | NAMES OF REPORTING PERSONS. I.R.S. Identification Nos. of above persons (entities only). A.J. Kazimi |
||||
2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) Not applicable |
||||
(a) o | |||||
(b) o | |||||
3 | SEC USE ONLY | ||||
4 | CITIZENSHIP OR PLACE OF ORGANIZATION | ||||
United States | |||||
5 | SOLE VOTING POWER | ||||
NUMBER OF | 5,517,775 | ||||
SHARES | 6 | SHARED VOTING POWER | |||
BENEFICIALLY | |||||
BY OWNED BY | None | ||||
EACH | 7 | SOLE DISPOSITIVE POWER | |||
REPORTING | |||||
PERSON | 5,517,775 | ||||
WITH: | 8 | SHARED DISPOSITIVE POWER | |||
None | |||||
9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | ||||
5,517,775 | |||||
10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) Not applicable |
||||
o | |||||
11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) | ||||
27.1% | |||||
12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) | ||||
IN |
Page 2 of 5 pages
(a) | Name of Issuer Cumberland Pharmaceuticals Inc. |
||
(b) | Address of Issuers Principal Executive Offices 2525 West End Avenue, Suite 950, Nashville, TN 37203 |
(a) | Name of Person Filing A.J. Kazimi |
||
(b) | Address of Principal Business Office or, if none, Residence 2525 West End Avenue, Suite 950, Nashville, TN 37203 |
||
(c) | Citizenship United States |
||
(d) | Title of Class of Securities Common Stock |
||
(e) | CUSIP Number 230770109 |
Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether
the person filing is a: Not applicable |
Page 3 of 5 pages
(a) | Amount beneficially owned: 5,517,775. |
||
(b) | Percent of class: 27.1%. |
||
(c) | Number of shares as to which the person has: |
(i) | Sole power to vote or to direct the vote 5,517,775. |
||
(ii) | Shared power to vote or to direct the vote None. |
||
(iii) | Sole power to dispose or to direct the disposition of 5,517,775. |
||
(iv) | Shared power to dispose or to direct the disposition of None. |
Page 4 of 5 pages
February 14, 2011 | ||
Date | ||
/s/ A.J. Kazimi | ||
Signature | ||
A.J. Kazimi | ||
Name/Title |
Page 5 of 5 pages